Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate plus calcium/vitamin D for osteopenia in Crohn's disease
NL-OMON27088Active, not recruiting
- Sponsor
- Sanofi
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in osteopenia and Crohn's disease comparing Actonel + calcium + vitamin D with Placebo + calcium + vitamin D (2 arms). Started Aug 2004; status: active, not recruiting.
02
Drugs
risedronate
03
Conditions
osteopeniaCrohn's disease
Beyond the preview
Go deeper on NL-OMON27088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27088.